SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-308678
Filing Date
2019-12-09
Accepted
2019-12-09 07:30:40
Documents
15
Period of Report
2019-12-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d800521d8k.htm   iXBRL 8-K 28532
2 EX-99.1 d800521dex991.htm EX-99.1 53831
3 EX-99.2 d800521dex992.htm EX-99.2 63887
7 GRAPHIC g800521g1206073500810.jpg GRAPHIC 3606
  Complete submission text file 0001193125-19-308678.txt   304246

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kpti-20191207.xsd EX-101.SCH 3076
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20191207_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20191207_pre.xml EX-101.PRE 11412
11 EXTRACTED XBRL INSTANCE DOCUMENT d800521d8k_htm.xml XML 3348
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 191274328
SIC: 2834 Pharmaceutical Preparations